These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17174426)

  • 1. CARD15 variants in patients with sporadic Parkinson's disease.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Juzwiak S; Kurzawski G; Tan EK; Drozdzik M
    Neurosci Res; 2007 Mar; 57(3):473-6. PubMed ID: 17174426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
    Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
    Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
    Ernst A; Jacobsen B; Østergaard M; Okkels H; Andersen V; Dagiliene E; Pedersen IS; Thorsgaard N; Drewes AM; Krarup HB
    Scand J Gastroenterol; 2007 Dec; 42(12):1445-51. PubMed ID: 17852840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs.
    Hradsky O; Lenicek M; Dusatkova P; Bronsky J; Nevoral J; Valtrova V; Kotalova R; Szitanyi P; Petro R; Starzykova V; Bortlik M; Vitek L; Lukas M; Cinek O
    Tissue Antigens; 2008 Jun; 71(6):538-47. PubMed ID: 18489434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease.
    Weiss B; Shamir R; Bujanover Y; Waterman M; Hartman C; Fradkin A; Berkowitz D; Weintraub I; Eliakim R; Karban A
    J Pediatr; 2004 Aug; 145(2):208-12. PubMed ID: 15289769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD15 gene variants in aggressive periodontitis.
    Noack B; Görgens H; Hoffmann T; Schackert HK
    J Clin Periodontol; 2006 Nov; 33(11):779-83. PubMed ID: 16965521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
    Barreiro-de Acosta M; Peña AS
    Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
    Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients.
    Giachino D; van Duist MM; Regazzoni S; Gregori D; Bardessono M; Salacone P; Scaglione N; Sostegni R; Sapone N; Bresso F; Sambataro A; Gaia E; Pera A; Astegiano M; De Marchi M
    Eur J Hum Genet; 2004 Mar; 12(3):206-12. PubMed ID: 14747834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease.
    Onnie CM; Fisher SA; Prescott NJ; Mirza MM; Green P; Sanderson J; Forbes A; Lewis CM; Mathew CG
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):37-45. PubMed ID: 18090989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
    Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
    Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease.
    Luoma PT; Eerola J; Ahola S; Hakonen AH; Hellström O; Kivistö KT; Tienari PJ; Suomalainen A
    Neurology; 2007 Sep; 69(11):1152-9. PubMed ID: 17846414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes.
    Bene J; Komlósi K; Magyari L; Talián G; Horváth K; Gasztonyi B; Miheller P; Figler M; Mózsik G; Tulassay Z; Melegh B
    Br J Nutr; 2007 Aug; 98(2):345-50. PubMed ID: 17391561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.